We found NOX4 is upregulated as a function of the clinical histopathological grade in bladder urothelial carcinoma, thyroid carcinoma, and esophageal carcinoma, suggesting that NOX4 may be involved in cancer progression (Figure 2). This evidence concerns the gene NOX4 and carcinoma of esophagus.